Zymeworks (ZYME) News Today → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free ZYME Stock Alerts $9.06 -0.14 (-1.52%) (As of 05/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - May 6 at 7:38 PMWells Fargo & Company Lowers Zymeworks (NYSE:ZYME) Price Target to $12.00americanbankingnews.com - May 5 at 5:16 AMCitigroup Lowers Zymeworks (NYSE:ZYME) Price Target to $16.00americanbankingnews.com - May 5 at 4:38 AMZymeworks (NYSE:ZYME) Price Target Lowered to $16.00 at Citigroupmarketbeat.com - May 3 at 9:15 PMOptimistic Buy Rating for Zymeworks: Anticipated Approvals and Strong Pipeline Potentialmarkets.businessinsider.com - May 3 at 8:24 PMBuy Rating Affirmed for Zymeworks on Strong Pipeline and Upcoming Catalystsmarkets.businessinsider.com - May 3 at 8:24 PMZymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 3 at 8:24 PMZymeworks Inc (ZYME) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...finance.yahoo.com - May 3 at 10:21 AMZymeworks Announces Participation in Upcoming Investor Conferencesglobenewswire.com - April 30 at 6:00 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - April 28 at 9:45 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - April 20 at 12:15 PMZymeworks (NYSE:ZYME) Shares Up 3.5%marketbeat.com - April 19 at 12:24 PMBuy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising Dataseekingalpha.com - April 18 at 6:22 PMLevi & Korsinsky Reminds Shareholders of an Investigation into Zymeworks Inc. (ZYME) Regarding Potential Securities Fraud Allegationsmarkets.businessinsider.com - April 16 at 6:55 PMMaintaining Hold on Zymeworks: ZW191’s Potential Amidst Competitive and Regulatory Hurdlesmarkets.businessinsider.com - April 12 at 6:42 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - April 12 at 9:30 AMZymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024globenewswire.com - April 11 at 6:00 AMZymeworks (NYSE:ZYME) Trading Down 2.6%marketbeat.com - April 9 at 11:46 AMZymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meetingglobenewswire.com - April 8 at 6:00 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - April 4 at 6:18 PMKirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)morningstar.com - April 4 at 7:39 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEstockhouse.com - April 2 at 5:54 PMZymeworks (NYSE:ZYME) Stock Price Down 6.7%marketbeat.com - April 1 at 3:29 PMZymeworks Inc. (NYSE:ZYME) Shares Purchased by Wellington Management Group LLPmarketbeat.com - March 29 at 4:09 AMZymeworks Inc.: Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directorsfinanznachrichten.de - March 28 at 10:14 AMZymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directorsglobenewswire.com - March 28 at 6:00 AMZymeworks Announces Participation in Upcoming Investor Conferencesglobenewswire.com - March 27 at 6:00 AMAnalysts’ Top Healthcare Picks: Zymeworks (ZYME), 89bio (ETNB)markets.businessinsider.com - March 13 at 6:44 PMAQR Capital Management LLC Has $5.07 Million Stock Holdings in Zymeworks Inc. (NYSE:ZYME)marketbeat.com - March 13 at 4:31 AMBuy Rating Affirmed for Zymeworks Amid Positive HERIZON Study Outlook and Robust Commercial Prospects of Zanidatamabmarkets.businessinsider.com - March 12 at 10:02 AMHold Rating on Zymeworks Amidst Pipeline Adjustments and Clinical Validation Awaitedmarkets.businessinsider.com - March 11 at 9:13 AMNext-Gen Winners: 7 Tech Stocks Set to Dominate the Decadeinvestorplace.com - March 8 at 10:18 AMZymeworks Inc.: Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 7 at 7:35 PMZymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 7:35 PMZymeworks Inc (ZYME) Reports Financial Results for Q4 and Full Year 2023finance.yahoo.com - March 7 at 2:35 PMZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 7 at 12:02 AMZymeworks Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - March 6 at 11:17 PMZymeworks Q4 2023 Earnings Previewmsn.com - March 6 at 7:24 PMZymeworks Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 6 at 4:09 PMRubric Capital Management LP Increases Holdings in Zymeworks Inc. (NYSE:ZYME)marketbeat.com - March 6 at 2:46 PMZymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meetingglobenewswire.com - March 5 at 4:30 PMZYME Apr 2024 7.500 callca.finance.yahoo.com - March 5 at 10:09 AMZYME Oct 2024 15.000 callca.finance.yahoo.com - March 5 at 10:09 AMZYME Mar 2024 20.000 callfinance.yahoo.com - March 5 at 12:17 AMZymeworks: A Strong Buy Amidst Zanidatamab's Promising Developmentsseekingalpha.com - March 5 at 12:16 AMZymeworks Inc. (NYSE:ZYME) Shares Sold by Deutsche Bank AGmarketbeat.com - March 4 at 4:34 AMZymeworks (NYSE:ZYME) Reaches New 12-Month High at $12.71marketbeat.com - February 27 at 10:44 AMZymeworks Announces Participation in Upcoming Investor Conferencesglobenewswire.com - February 27 at 6:00 AMAcadian Asset Management LLC Acquires 727,934 Shares of Zymeworks Inc. (NYSE:ZYME)marketbeat.com - February 24 at 6:45 AMZYME Apr 2024 10.000 putfinance.yahoo.com - February 22 at 9:02 PM Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide ZYME Media Mentions By Week ZYME Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZYME News Sentiment▼-0.190.40▲Average Medical News Sentiment ZYME News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZYME Articles This Week▼122▲ZYME Articles Average Week Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MLYS News WVE News ORIC News NRIX News COGT News SIGA News DNTH News PHAR News SVRA News CALT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ZYME) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zymeworks Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.